Journal profile · Medicine-Radiology, Nuclear Medicine and Imaging

CVIR Endovascular

ISSN 2520-8934 · Springer Nature · United Kingdom

CVIR Endovascular: CAS Zone 4 · Medicine (2025 upgraded edition); impact factor 2.1 (journal website); fully open access; APC about USD 2,690; median 75 days to acceptance (101 articles, last 24 months); 122 articles in 2025; indexed in ESCI and Scopus.

Impact factor2.1From the journal's website, 2025 value
CAS zoneZone 4 · Medicine2025 upgraded edition, major category · 2026 Xinrui edition Zone 4 · Medicine
Review time75 daysMedian, submission to acceptance · 101 articles, last 24 months · Crossref
APCUSD 2,690Fully open access
Acceptance—No reports yet
Articles per year1222025 · OpenAlex count

Scope

Aims, scope and focus

CVIR Endovascular is published by Springer Nature and is in Zone 4 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Peripheral Artery Disease Management, Vascular Procedures and Complications and Central Venous Catheters and Hemodialysis, together about 25.8% of its articles. Its main subfields are Surgery and Pulmonary and Respiratory Medicine. (generated from OpenAlex topic counts and CAS ranking data)

CVIR Endovascular is the multidisciplinary open access journal in the field of endovascular therapies. The journal publishes peer-reviewed papers on endovascular interventions and is intended for all specialists with an interest in vascular disease. CVIR Endovascular publishes a wide range of manuscript types including original scientific papers, review articles, commentaries, technical reports, case reports and letters to the editor. CVIR Endovascular welcomes submissions on arterial interventions, venous interventions, non-oncological embolization including trauma, aortic interventions, vascular malformations, and neuro interventions. The field of endovascular treatment is dynamic, and new ideas need rapid communication so that the latest information is available to treat our patients. CVIR Endovascular provides an excellent podium to discuss your research work with your peers. CVIR Endovascular is an official journal of the Cardiovascular and Interventional Radiological Society of Europe (CIRSE). As part of the CIRSE journal family, it embodies the society’s dedication to promoting excellence in research and clinical practice, fostering innovation, and advancing patient care within the global vascular community.

From the journal's Aims & Scope

Research area (LetPub): Medicine-Radiology, Nuclear Medicine and Imaging

Editor-in-chief Robert A. MorganPublisher website

Editorial board by country: 1 in mainland China (about 2%); most named United Kingdom 15, Germany 5, Italy 3, Netherlands 3, Switzerland 3 (51 members with a country) Editorial board ↗Publisher website ·

Main research topics OpenAlex counts of recent articles; shares are approximate

  1. Peripheral Artery Disease ManagementMedicine9.8%
  2. Vascular Procedures and ComplicationsMedicine9%
  3. Central Venous Catheters and HemodialysisHealth Professions6.9%
  4. Aortic aneurysm repair treatmentsMedicine6.6%
  5. Abdominal vascular conditions and treatmentsMedicine5.8%
  6. Vascular Anomalies and TreatmentsMedicine5.8%
  7. Venous Thromboembolism Diagnosis and ManagementMedicine4.8%
  8. Infectious Aortic and Vascular ConditionsMedicine4.7%

Rankings & indexing

CAS ranking and database indexing

CAS Journal Ranking

CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 4
LevelCategoryZone
MajorMedicineZone 4
MinorCardiac & Cardiovascular SystemsZone 4
MinorPeripheral Vascular DiseaseZone 4
MinorRadiology, Nuclear Medicine & Medical ImagingZone 4

Top journal: noReview journal: no

CAS Xinrui Journal Ranking (March 2026)Medicine Zone 4
LevelCategoryZone
MajorMedicineZone 4
MinorCardiac & Cardiovascular SystemsZone 4
MinorRadiology, Nuclear Medicine & Medical ImagingZone 4
MinorPeripheral Vascular DiseaseZone 4

Top journal: noReview journal: not marked

CAS Journal Ranking, previous upgraded edition (December 2023)Not covered

Not covered by this edition.

Database indexing

ESCIScopusDOAJLetPub

International journal early-warning lists: not listed in any editionLetPub

Indexing the journal's website claims

EmbasePublisher website

Other: Google Scholar, EBSCO, ProQuest, Dimensions, CNKI, Baidu, Naver, OCLC, Portico, CLOCKSS, Semantic Scholar

As the journal's website lists them, not checked against each database; for Web of Science editions the records above apply.

Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.

Metrics

Impact metrics and publication volume

Impact

Impact factor (publisher) 2025
2.1Publisher website ·
5-year impact factor (publisher) 2025
1.7Publisher website ·
CiteScore 2026-06
2.2LetPub ·
SJR 2026-06
0.49LetPub ·
SNIP 2026-06
1.24LetPub ·
h-index
25OpenAlex ·
i10-index
138OpenAlex ·
2-year mean citedness
1.96OpenAlex ·
Self-citation rate
9.5%LetPub ·
Share of gold OA articles
100%LetPub ·

Volume

Articles per year
109LetPub ·
Downloads per year (publisher) 2025
498,100Publisher website ·

Articles by year OpenAlex count · 737 in total · the current year is incomplete

YearArticlesOpen accessCitations
202612512521
2025122122196
20249292448
20236363493
20226868395
20218888739

Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.

Review & acceptance

Review time and acceptance

Review time from article dates manuscript dates registered with Crossref · to

75 daysMedian, submission to acceptance · P25–P75 48 days – 109 days

Acceptance to online
median 25 days (101 articles)
Submission to online
median 108 days
Sample
101 articles with submission and acceptance dates (267 in the window); the latest was accepted on

Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".

Other sources

Average review time (community reports)
about 5 weeksLetPub ·
Submission to first decision
11 daysPublisher website ·
Submission to publication (journal-reported)
about 5 weeksDOAJ ·
Peer review
Open peer reviewDOAJ

Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.

Fees & open access

APC and open-access policy

Fully open accessDOAJ

Every article is open access; authors usually pay an article processing charge (APC).

SourceAPCFee waiverLicenseObserved
DOAJEUR 2,290 / USD 2,690 / GBP 1,990YesCC BY
OpenAlexUSD 2,590 / EUR 2,190 / GBP 1,890——
LetPubGBP 1,690 / USD 2,390 / EUR 1,990Yes—
Publisher websiteGBP 1,990 / USD 2,690 / EUR 2,290——

The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.

Submission

Article types and submission policies (journal website)

What to prepare2 items from the author guidelines
Suggested reviewers
Optional
Not considered
requests made during the review process or after acceptance
Publisher website · model-extracted, each line checked against the text
Article types accepted9
  1. case reportCase Report New technologies Original Article Review article Study protocol Short Communication Letter to the Editor Editorial Standards of PracticeLength not stated
  2. editorialCase Report New technologies Original Article Review article Study protocol Short Communication Letter to the Editor Editorial Standards of PracticeLength not stated
  3. letter to the editorCase Report New technologies Original Article Review article Study protocol Short Communication Letter to the Editor Editorial Standards of PracticeLength not stated
  4. new technologiesCase Report New technologies Original Article Review article Study protocol Short Communication Letter to the Editor Editorial Standards of PracticeLength not stated
  5. original articleCase Report New technologies Original Article Review article Study protocol Short Communication Letter to the Editor Editorial Standards of PracticeLength not stated
  6. review articleCase Report New technologies Original Article Review article Study protocol Short Communication Letter to the Editor Editorial Standards of PracticeLength not stated
  7. short communicationCase Report New technologies Original Article Review article Study protocol Short Communication Letter to the Editor Editorial Standards of PracticeLength not stated
  8. standards of practiceCase Report New technologies Original Article Review article Study protocol Short Communication Letter to the Editor Editorial Standards of PracticeLength not stated
  9. study protocolCase Report New technologies Original Article Review article Study protocol Short Communication Letter to the Editor Editorial Standards of PracticeLength not stated
Publisher website
Policy excerpts from the journal's websiteData availability, License & copyright, Open access, Peer review
Data availability Formatting the 'Availability of data and materials' section of your manuscript

Data sharing strongly encouraged or required; deposit in public repositories where appropriate. Model summary

The following format for the 'Availability of data and materials section of your manuscript should be used:

Source ↗Publisher website ·
License & copyright Licensing and copyright

Open access under CC BY licence. Model summary

Creative Commons licences Open access articles in Springer Nature journals are published under Creative Commons licences. These provide an industry-standard framework to support easy re-use of open access material. Under Creative Commons licences, authors retain copyright of their articles. CVIR Endovascular articles are published open access under a CC BY licence (Creative Commons Attribution 4.0…

Source ↗Publisher website ·
Open access Benefits of open access

Publishing open access (OA) offers a number of benefits, including greater reach and readership for your work: Cited more 1.6x more citations of OA articles than non-OA articles across all subjects Downloaded more 4x more downloads of OA articles than non-OA articles Greater impact 2.5x more Altmetric attention. OA articles attracted 1.9x more news mentions and 1.2x more policy mentions Open acces…

Source ↗Publisher website ·
Peer review Peer review policy

Peer review is the process used to evaluate the quality of a manuscript before publication. Independent researchers in the relevant field assess submitted manuscripts to check their validity and robustness. Their feedback guides editors in making publication decisions. Typically, two or more experts evaluate each manuscript based on three main criteria: scientific robustness: is the research metho…

Source ↗Publisher website ·

Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.

Profile

Publication details and official links

Publisher
Springer Nature
Country or region
United Kingdom
Language
English
ISSN
2520-8934
Society / sponsor
Cardiovascular and Interventional Radiological Society of Europe
Official links

FAQ

Frequently asked questions about CVIR Endovascular

What CAS zone is CVIR Endovascular in?

In the 2025 upgraded edition of the CAS Journal Ranking, CVIR Endovascular is in Zone 4 of Medicine, and in Zone 4 of the minor category Cardiac & Cardiovascular Systems / Peripheral Vascular Disease / Radiology, Nuclear Medicine & Medical Imaging. In the 2026 Xinrui edition it is in Zone 4 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.

What is the impact factor of CVIR Endovascular?

The journal's website gives an impact factor of 2.1 (2025); this is the journal's own figure, as LetPub lists none for it; CiteScore 2.2, h-index 25.

How long does peer review take at CVIR Endovascular?

Based on the dates recorded on 101 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 75 days (interquartile range 48–109 days); authors report an average review time of about 5 weeks. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.

Where are the editorial board members of CVIR Endovascular based?

Of the 51 board members whose country the journal's board page names, 1 (about 2%) are in mainland China; the countries named most often are United Kingdom (15), Germany (5) and Italy (3). Counted from the institutions listed on the board page; for reference only.

Which databases index CVIR Endovascular?

According to LetPub and DOAJ records, CVIR Endovascular is indexed in ESCI, Scopus and DOAJ. The journal's website also lists Embase; that list has not been checked against each database.

Is CVIR Endovascular open access, and what is the APC?

CVIR Endovascular is a fully open-access journal. APC about USD 2,690.

Sources and updates

The facts on this page come from LetPub, OpenAlex, DOAJ, Publisher website; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-25). Last updated: .